Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC
Accepted 2025-02-12 00:00:00 ET · period of report 2025-02-10 · accession 0001062993-25-002181 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-12 | 2025-02-10 | COLL | Heffernan Michael Thomas | Dir | A - Grant | $0.00 | +4,820 | 50.3K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-10 | A | A | 4,820 | $0.00 | 50,328 | D | — | — | (F1) Reflects the grant of fully-vested restricted stock units ("RSUs") granted as compensation for the Reporting Person's service as interim Chief Executive Officer in 2024. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |